Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest special notice from .

Solicitation number
75N95020Q00025
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

The purpose of this requirement is to procure services of small molecules and biologics drug discovery and development consultants to provide technical development recommendations to the NIDA Step Up for Substance Use Disorder (SUD) program.

Files

File Type Posted
FAR 52.212-5 clause.pdf PDF
DDD consultants-SOW (Final).doc DOC document
52.204-24_please sign.pdf PDF
CSS_DDD consultant.pdf PDF

Notice history

Notice Type Posted
Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA) Award Award Notice
Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA) Latest special notice Special Notice
This notice Original Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors